In Other News

• Compact Immunoanalyzer Gains CE Mark for Testing Across Local Care Settings

• Updated Framework Guides Assessment of Actionable Cancer Biomarkers

• Genomic Tissue Test Predicts Metastasis and Abiraterone Benefit in High-Risk Prostate Cancer

• RNA Sequencing Assay Gains EU Certification for Solid Tumor Profiling

• Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

• Lung Tumor RNA Variants Offer Clues to Immunotherapy Benefit

• Six-Gene Score Improves Prognosis Prediction in Acute Myeloid Leukemia

• Long-Read Sequencing Reveals Cancer-Driving Changes Missed by Conventional Testing

• Whole-Genome MRD Test Detects Traces of Cancer During and After Treatment

• Collaboration Brings Tumor-Informed MRD Monitoring to Breast Cancer Care in Abu Dhabi

• Real Diagnostics Adds Saliva-Based Periodontal Testing With SimplyTest Deal

• Common Kidney Function Tests May Miss CKD in Cancer Patients

• New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

• Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows

• Population-Scale Genome Survey Supports Interpretation of Genetic Testing

• AI Model Improves Breast Cancer Survival Prediction

• Six-Gene Score Improves Prognosis Prediction in Acute Myeloid Leukemia

• Population-Scale Genome Survey Supports Interpretation of Genetic Testing

• Qiagen Agrees to Go Private Through EQT-Led Acquisition

• Point-of-Care Blood Biomarker Test Detects Brain Injury Missed by CT

• Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

• AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer

• Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use